COX-2 Advisory Cmte. Was Unbiased Crawford Says; Conflict Policy To Stay
Executive Summary
FDA may consider having an ethics counselor present at the start of advisory committee meetings as part of an agency plan to reduce potential conflicts of interest, although the current policy will largely remain intact
You may also be interested in...
Draft Conflict Of Interest Policy Affects Status Of Many FDA Cmte. Members
A "significant fraction" of current FDA advisory committee members' eligibility to vote and participate in meetings would be affected by a revised conflict of interest policy, FDA said
Advisory Panelist Conflicts Of Interest Have Weak Favorable Effect On Votes
FDA advisory committee members with conflicts of interest are more likely to vote favorably for the drug being discussed than those without conflicts, a study conducted by Public Citizen's Health Research Group found
Advisory Panelist Conflicts Of Interest Have Weak Favorable Effect On Votes
FDA advisory committee members with conflicts of interest are more likely to vote favorably for the drug being discussed than those without conflicts, a study conducted by Public Citizen's Health Research Group found